THE nature of the valvular lesions in subacute bacterial endocarditis makes the use of anticoagulants appear a logical procedure in the prevention of fibrin formation. Such agents should thereby keep ...

"Patients with cancer-associated thrombosis are both at risk of recurrent venous thromboembolism and bleeding during extended ...

THE value of coumarin anticoagulant therapy in both the prevention and the treatment of postoperative thromboembolic disease is well established. 1 Patients who have external (T-tube) drainage of the ...

Anticoagulant therapy for ischaemic stroke aims to prevent recurrent ischaemic stroke and venous thromboembolism. Several large clinical trials have provided insight into the safety and efficacy of ...

Three or 6 months of anticoagulant therapy used to be the standard duration of treatment for almost all patients after a first episode of deep vein thrombosis or pulmonary embolism (collectively ...

Objective: To provide recommendations, policies, and procedures pertaining to the provision of optimized anticoagulation therapy designed to achieve desired clinical endpoints while minimizing the ...

Heparin. UFH is one of two agents that comprise conventional anticoagulant therapy. It is considered a natural agent and has been the standard of care for many years. Its mechanism of action is ...

Background: Patients taking oral anticoagulant therapy balance the risks of hemorrhage and thromboembolism. We sought to determine the association between anticoagulation intensity and the risk of ...

Combining a new-generation oral anticoagulant with standard dual antiplatelet therapy to protect patients against ischemic events in the wake of an acute coronary syndrome (ACS) dramatically increases ...

Patients with atrial fibrillation who took oral anticoagulants alone after undergoing transcatheter aortic valve replacement (TAVR) had a lower rate of bleeding complications without an increased risk ...

During this segment, Michael A. Evans, BS, RPh, discusses the importance of initiating anticoagulation for patients at risk of developing thromboembolic complications. However, he recognizes that the ...

Please provide your email address to receive an email when new articles are posted on . Hormonal therapy did not appear associated with an increased risk for recurrent venous thromboembolism or ...